SureStart™ MFGM Lipids
Brain development is often sited as one of the most important considerations of parents, and a top purchase driver of infant formula.
The Milk Fat Globule Membrane (MFGM), naturally present in milk, is clinically shown to support brain development and cognition in infants.
Disclaimer: Product image is for promotional purposes only. The representation on your screen may be different from the actual product for various reasons. Religious/dietary status is indicative only and may vary between material numbers.
Supports brain development and cognition
Top purchase drivers for parents.
A composition more similar to breast milk
Getting closer to the gold standard.
Backed by science
Investing in world-leading research.
We have two MFGM Lipid ingredients in the range to provide manufacturers with more flexibility to develop new and innovative infant formula products. Our ingredients, SureStartTM MFGM Lipid 100 and SureStartTM MFGM Lipid 70, are a source of MFGM gangliosides and phospholipids, including sphingomyelin.
SureStartTM MFGM Lipid 100 has been recognised throughout the industry for innovation and ingenuity, including the winner of the 2018 NutraIngredients Asia 'Ingredient of the Year' awards in the Infant Nutrition Category.
SureStart™ MFGM Lipid 100
NZMP SureStart™ Lipid 100 is made during the manufacture of anhydrous milk fat from cream.
This product is manufactured in New Zealand with specifications tailored for wet blend processing of maternal and paediatric products.
SureStart™ MFGM Lipid 70
NZMP SureStart™ Lipid 70 is made during the manufacture of whey protein isolate from cheese whey.
This product is manufactured in New Zealand and The Netherlands with specifications for wet processing of paediatric products.
Two different ingredients available to enable formulation flexibility.
Suitable for maternal and paediatric applications for infants and young children.
Clinical studies on MFGM Lipids
A number of studies have shown the potential benefits of MFGM containing ingredients for infant cognitive development.
- In a pilot study in Indonesia (Gurnida et al. 2012), healthy term infants fed a ganglioside-enriched infant formula from < 2 months to 6 months of age had higher hand-eye coordination, performance and general IQ scores (measured with the Griffith Scale) at 6 months of age than infants fed a standard infant formula.
- In a small study in Japan (Tanaka et al. 2013), very low birth weight preterms who received a formula enriched in milk sphingomyelin in addition to breast milk had higher developmental scores at 6, 12 and 18 months of age than infants who received a formula enriched with egg sphingomyelin.
- In a study in Sweden, healthy term infants who received an MFGM-enriched infant formula from < 2 months to 6 months of age had a higher cognitive score (measured with the Bayley Scales of Infant and Toddler Development, 3rd edition) at 12 months of age than infants fed a standard infant formula, but was not different to breastfed infants.
- In a study in China (Xia et al.), healthy term infants who received an MFGM-rich formula from < 14 days to 12 months of age had higher general adaptive score (measured with Bayley-III) at 12 months of age compared with infants who received a non-supplemented formula.
